Date: 24 September 2024
Time: 10:00 – 16:00
Location: Linbury Building, Oxford OX1 2TA, UK
Oxford Symposium
"T-cells and Antigen-Specificity – Applications in Infectious Disease and Immuno-Oncology"
In September, Immudex will be hosting a symposium in Oxford where scientists will give presentations about their research in the area of T cells and antigen specifity.
This event is free to attend but the number of places is limited so please register to secure your seat.
Registration is now closed.
| 10:00-10:20 | Morning coffee/tea |
| 10:20-10:30 | Opening talk |
| 10:30-11:00 |
Dr. Nicola Ternette, Professor, University of Dundee “Advancing into non-canonical cancer antigen discovery” |
| 11:00-11:30 |
Dr. Simon Davis, Professor, University of Oxford "Translational applications of the kinetic-segregation principle” |
| 11:30-12:00 |
Dr. Thomas Holberg Blicher, Principal Scientist, Immudex "TCR Discovery and Validation” |
| 12:00-13:00 | Lunch & Get Together |
| 13:00-13:30 |
Dr. Andrew Sewell, Professor, Cardiff University “MHC-related protein 1-restricted recognition of cancer via a semi-invariant TCR-alpha chain” |
| 13:30-14:00 |
Dr. Tao Dong, Professor, University of Oxford TBA |
| 14:00-14:30 |
Dr. Sebastian Klein, Hannover Medical School "Targeted single-cell sequencing of epitope-specific CD8+ T cells in chronic viral infections" |
| 14:30-15:00 |
Dr. Mohammad Salem, Senior Pharma Business & Solution Manager, Immudex "Artificial Antigen-Presenting Scaffolds: A Tailored Approach for T-Cell Stimulation and Expansion" |
| 15:00-16:00 |
Networking |
Meet the Team
Mohammad Salem, PhD
Senior Pharma Business & Solution Manager
Michela Venturi, PhD
Sales Development Manager
Thomas Holberg Blicher, PhD
Principal Scientist